Invention Grant
- Patent Title: Monocyclic compounds useful as GPR120 modulators
-
Application No.: US17959064Application Date: 2022-10-03
-
Publication No.: US12116362B2Publication Date: 2024-10-15
- Inventor: Brian Raimundo , Elena S. Koltun , John Griffin , Eric Stangeland
- Applicant: Valo Health, Inc.
- Applicant Address: US MA Boston
- Assignee: Valo Health, Inc.
- Current Assignee: Valo Health, Inc.
- Current Assignee Address: US MA Boston
- Agency: Foley & Lardner LLP
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61P1/16 ; A61P3/10 ; A61P25/16 ; A61P25/28 ; A61P29/00 ; C07D401/04 ; C07D401/14 ; C07D417/04 ; C07D471/04
Abstract:
Provided herein are compounds, compositions including them, and methods of modulating GPR120 activity and treating diseases mediated by GPR120 by administering such compounds and compositions.
Public/Granted literature
- US20230183231A1 MONOCYCLIC COMPOUNDS USEFUL AS GPR120 MODULATORS Public/Granted day:2023-06-15
Information query
